Oramed Pharmaceuticals (ORMP) Q2 2023 Earnings

9AugExpected
Nov 22
Jan 23
Q1 2023
Q2 2023
-0.26
-0.2
-0.14
-0.08

Details

Expected EPS
-0.1
Actual EPS
-0.08
Surprise EPS
0.02
Surprise Percent
+20%

Description

Oramed Pharmaceuticals (ORMP) has reported earnings of -0.08 per share for Q2 2023.

0 Comments

Share your thoughts